GlassScriptPhysician profile
Lisa Baker
NPI 1114332814
$1,031.94
in general payments reported to CMS, 2019-2025
22 companies · $45.19 in 2025
The $45.19 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $712 · 2023: $50.87 · 2025: $45.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $96.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $96.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $251.48 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $97.43 | 2022 | |
| Amgen INC. | $78.24 | 2021-2023 | Vectibix, Xgeva, Nplate |
| E.R. Squibb & Sons, L.L.C. | $59.82 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $58.25 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.80 | 2021-2022 | |
| Celgene Corporation | $48.19 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.90 | 2022 | |
| Glaxosmithkline, LLC. | $39.57 | 2021-2022 | |
| Genzyme Corporation | $38.88 | 2021-2022 | |
| Genentech USA, INC. | $36.75 | 2021 | |
| Exact Sciences Corporation | $36.25 | 2023 | Cologuard Collection Kit |
| Pharmacyclics LLC, An Abbvie Company | $36.06 | 2022 | |
| Janssen Biotech, INC. | $29.93 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.71 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $19.32 | 2025 | Kcentra |
| Eisai INC. | $19.00 | 2022 | |
| Incyte Corporation | $13.55 | 2021 | |
| Lilly USA, LLC | $13.37 | 2021 | |
| Sobi, INC | $13.29 | 2022 | |
| Dova Pharmaceuticals | $12.90 | 2021 | |
| Pfizer INC. | $12.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.